These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38203723)

  • 1. Exploring the Mechanism of Activation of CFTR by Curcuminoids: An Ensemble Docking Study.
    Bellacchio E
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains.
    Wang W; Bernard K; Li G; Kirk KL
    J Biol Chem; 2007 Feb; 282(7):4533-4544. PubMed ID: 17178710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Basis for Fe(III)-Independent Curcumin Potentiation of Cystic Fibrosis Transmembrane Conductance Regulator Activity.
    Wang G
    Biochemistry; 2015 May; 54(18):2828-40. PubMed ID: 25867080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the interactions between nucleotide binding domains and membrane spanning domains in cystic fibrosis transmembrane regulator: A molecular dynamic study.
    Belmonte L; Moran O
    Biochimie; 2015 Apr; 111():19-29. PubMed ID: 25640670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening.
    Wang W; Roessler BC; Kirk KL
    J Biol Chem; 2014 Oct; 289(44):30364-30378. PubMed ID: 25190805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of a nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator yields insight into disease-causing mutations.
    Vernon RM; Chong PA; Lin H; Yang Z; Zhou Q; Aleksandrov AA; Dawson JE; Riordan JR; Brouillette CG; Thibodeau PH; Forman-Kay JD
    J Biol Chem; 2017 Aug; 292(34):14147-14164. PubMed ID: 28655774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
    Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
    Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel.
    Tsai MF; Li M; Hwang TC
    J Gen Physiol; 2010 May; 135(5):399-414. PubMed ID: 20421370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog.
    Bompadre SG; Li M; Hwang TC
    J Biol Chem; 2008 Feb; 283(9):5364-9. PubMed ID: 18167357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
    Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
    J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
    Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
    Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The most common cystic fibrosis-associated mutation destabilizes the dimeric state of the nucleotide-binding domains of CFTR.
    Jih KY; Li M; Hwang TC; Bompadre SG
    J Physiol; 2011 Jun; 589(Pt 11):2719-31. PubMed ID: 21486785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct sensing of intracellular pH by the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel.
    Chen JH; Cai Z; Sheppard DN
    J Biol Chem; 2009 Dec; 284(51):35495-506. PubMed ID: 19837660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can two wrongs make a right? F508del-CFTR ion channel rescue by second-site mutations in its transmembrane domains.
    Prins S; Corradi V; Sheppard DN; Tieleman DP; Vergani P
    J Biol Chem; 2022 Mar; 298(3):101615. PubMed ID: 35065958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.
    Okeyo G; Wang W; Wei S; Kirk KL
    J Biol Chem; 2013 Jun; 288(24):17122-33. PubMed ID: 23620589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis transmembrane conductance regulator: a chloride channel gated by ATP binding and hydrolysis.
    Bompadre SG; Hwang TC
    Sheng Li Xue Bao; 2007 Aug; 59(4):431-42. PubMed ID: 17700963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of the degenerated interfacial ATP binding site improves the function of disease-related mutant cystic fibrosis transmembrane conductance regulator (CFTR) channels.
    Tsai MF; Jih KY; Shimizu H; Li M; Hwang TC
    J Biol Chem; 2010 Nov; 285(48):37663-71. PubMed ID: 20861014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.
    Zeltwanger S; Wang F; Wang GT; Gillis KD; Hwang TC
    J Gen Physiol; 1999 Apr; 113(4):541-54. PubMed ID: 10102935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Zn(2+) binding to cysteine-substituted cystic fibrosis transmembrane conductance regulator constructs regulates channel gating and curcumin potentiation.
    Wang G; Linsley R; Norimatsu Y
    FEBS J; 2016 Jul; 283(13):2458-75. PubMed ID: 27175795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.